Autoimmune Haemolytic Anaemia and Mefenamic Acid Therapy
Authors:
- G. L. ScottGSG. L. Scott
- A. B. MylesAMA. B. Myles
- P. A. BaconPBP. A. Bacon
Abstract
Three patients developed autoimmune haemolytic anaemia while being treated with mefenamic acid. In each case the autoimmune haemolytic anaemia was of the warm antibody γG type, and the antibodies had some rhesus specificity. All three patients recovered when the drug was withdrawn. Attempts to inhibit or enhance the activity of the antibody in vitro were unsuccessful. Direct antihuman globulin tests were made in.the red cells of 36 patients receiving long-term mefenamic acid therapy, but only one was found to be transitorily positive.Keywords
This publication has 6 references indexed in Scilit:
- Mefenamic acid in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1967
- The Nature of the Alpha-Methyldopa Red-Cell AntibodyNew England Journal of Medicine, 1967
- Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis.BMJ, 1966
- AUTOIMMUNE HÆMOLYTIC ANÆMIA ASSOCIATED WITH α-METHYLDOPA THERAPYThe Lancet, 1966
- INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPAThe Lancet, 1966
- TRIAL OF MEFENAMIC ACIDRheumatology, 1965